Endovision is a non-profit organization dedicated to the innovation and advancement of medical devices for the treatment of digestive tract diseases and cancers. Through a physician-driven incubator model, Endovision works to develop novel endoscopic techniques, procedures, and devices that provide less invasive treatment options for patients. The foundation prioritizes innovations that serve patients effectively while maintaining affordability.
2200 Sacramento St, Apt 1105, San Francisco, California, 94115
View all San Francisco charities2020
85-1511291
$530.9 thousand
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Endovision advocates for early detection of digestive tract cancers using advanced endoscopic tools, emphasizing non-surgical options.
In honor of Michael T. MacLaughlin, the foundation remembers his contributions to advancing endoscopic innovation.
Endovision creates prototypes addressing unmet medical needs, focusing on simplicity, ease of use, and cost-effectiveness.
Overall Score
56
62
/100
Program Expense Ratio
95.92%
20
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0.00515
20
/20
Working Capital Ratio
5.514
18
/20
Fundraising Efficiency
0
2
/20
Fiscal Year:2022
Source:Source: Self-reported by organization
Category | Amount | Percentage |
---|---|---|
Contributions, Gifts, and Grants | 153K | 93.04% |
Program Services | 0 | 0.00% |
Investment Income | 11.45K | 6.96% |
Sales of Non-Inventory Assets | 0 | 0.00% |
Other Notable Sources | 0 | 0.00% |
Total Revenue | 164.5K | 100.00% |
Med Research
Gastroenterology ResearchMed Research
Gastroenterology ResearchMed Research
Gastroenterology ResearchMed Research
Gastroenterology ResearchMed Research
Gastroenterology Research